UK cereal manufacturer Weetabix today (1 September) announced the appointment of Giles Turrell as CEO.

Turrell, who will take on the role next month, replaces Ken Wood, who is retiring after seven years at the helm of the company, which is owned by private-equity firm Lion Capital.

He will join Weetabix from paper goods company Kimberly-Clark, where he is president of its European consumer business.

He has served in a number of senior marketing and general management roles across different categories, initially with GlaxoSmithKline and, since 1997, with Kimberley-Clark.

Turrell said: “Weetabix is a robust and innovative business with a great portfolio of brands in a dynamic category. I am looking forward to working with the Weetabix team enormously.”

Wood added: “I’d like to record my thanks for all the help, friendship and support that I’ve enjoyed. I am happy that I leave the business both in good shape and in good hands.”